Cargando…
Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391442/ https://www.ncbi.nlm.nih.gov/pubmed/37202995 http://dx.doi.org/10.4103/IJO.IJO_71_23 |
| _version_ | 1785082708607631360 |
|---|---|
| author | Ariga, Murali Nivean, Pratheeba Devi |
| author_facet | Ariga, Murali Nivean, Pratheeba Devi |
| author_sort | Ariga, Murali |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10391442 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103914422023-08-02 Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial Ariga, Murali Nivean, Pratheeba Devi Indian J Ophthalmol Letters to the Editor Wolters Kluwer - Medknow 2023-05 /pmc/articles/PMC10391442/ /pubmed/37202995 http://dx.doi.org/10.4103/IJO.IJO_71_23 Text en Copyright: © 2023 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letters to the Editor Ariga, Murali Nivean, Pratheeba Devi Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial |
| title | Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial |
| title_full | Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial |
| title_fullStr | Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial |
| title_full_unstemmed | Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial |
| title_short | Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial |
| title_sort | response to comments on: efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: the indian carbonic anhydrase inhibitor trial |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391442/ https://www.ncbi.nlm.nih.gov/pubmed/37202995 http://dx.doi.org/10.4103/IJO.IJO_71_23 |
| work_keys_str_mv | AT arigamurali responsetocommentsonefficacyofdorzolamideinimprovingocularbloodflowinpatientswithopenangleglaucomatheindiancarbonicanhydraseinhibitortrial AT niveanpratheebadevi responsetocommentsonefficacyofdorzolamideinimprovingocularbloodflowinpatientswithopenangleglaucomatheindiancarbonicanhydraseinhibitortrial |